Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 7653689, 6 pages
http://dx.doi.org/10.1155/2016/7653689
Research Article

Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease

1Department of Internal Medicine, Healthcare Research Institute, Gangnam Healthcare Center, Seoul National University Hospital, Seoul, Republic of Korea
2Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA
3Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea

Received 21 September 2016; Revised 10 November 2016; Accepted 17 November 2016

Academic Editor: Paul Enck

Copyright © 2016 Goh Eun Chung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. D. Lee, A. R. Folsom, F. J. Nieto, L. E. Chambless, E. Shahar, and D. A. Wolfe, “White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study,” American Journal of Epidemiology, vol. 154, no. 8, pp. 758–764, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Nakanishi, H. Yoshida, Y. Matsuo, K. Suzuki, and K. Tatara, “White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men,” Diabetologia, vol. 45, no. 1, pp. 42–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Lohsoonthorn, B. Dhanamun, and M. A. Williams, “Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations,” American Journal of Hypertension, vol. 19, no. 4, pp. 339–345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-J. Lee, H.-R. Lee, J.-Y. Shim, B.-S. Moon, J.-H. Lee, and J.-K. Kim, “Relationship between white blood cell count and nonalcoholic fatty liver disease,” Digestive and Liver Disease, vol. 42, no. 12, pp. 888–894, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Vernon, A. Baranova, and Z. M. Younossi, “Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults,” Alimentary Pharmacology and Therapeutics, vol. 34, no. 3, pp. 274–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Korean Association for the Study of the Liver (KASL), “KASL clinical practice guidelines: management of nonalcoholic fatty liver disease,” Clinical and molecular hepatology, vol. 19, no. 4, pp. 325–348, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Angulo, “Nonalcoholic fatty liver disease,” New England Journal of Medicine, vol. 346, no. 16, pp. 1221–1231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Khashab, S. Liangpunsakul, and N. Chalasani, “Nonalcoholic fatty liver disease as a component of the metabolic syndrome,” Current Gastroenterology Reports, vol. 10, no. 1, pp. 73–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. E. Chung, J. Y. Yim, M. J. Park et al., “Severity of nonalcoholic fatty liver disease is associated with development of metabolic syndrome: results of a 5-year cohort study,” Journal of Liver Research, Disorders & Therapy, vol. 1, no. 2, pp. 122–126, 2015. View at Publisher · View at Google Scholar
  12. R. Hernaez, M. Lazo, S. Bonekamp et al., “Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis,” Hepatology, vol. 54, no. 3, pp. 1082–1090, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. P. W. F. Wilson, R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, “Prediction of coronary heart disease using risk factor categories,” Circulation, vol. 97, no. 18, pp. 1837–1847, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Saadeh, Z. M. Younossi, E. M. Remer et al., “The utility of radiological imaging in nonalcoholic fatty liver disease,” Gastroenterology, vol. 123, no. 3, pp. 745–750, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Habibzadeh, P. Habibzadeh, and M. Yadollahie, “On determining the most appropriate test cut-off value: the case of tests with continuous results,” Biochemia Medica, vol. 26, no. 3, pp. 297–307, 2016. View at Publisher · View at Google Scholar
  16. G. Kuppan, R. M. Anjana, M. Deepa et al., “Inflammatory markers in relation to nonalcoholic fatty liver disease in urban South Indians,” Diabetes Technology and Therapeutics, vol. 14, no. 2, pp. 152–158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Wang, C. Zhang, G. Zhang et al., “Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study,” BMJ Open, vol. 6, no. 6, Article ID e010342, 2016. View at Publisher · View at Google Scholar
  18. S. B. Yoon, J. M. Park, C. H. Lim et al., “Incidence of gastric cancer after endoscopic resection of gastric adenoma,” Gastrointestinal Endoscopy, vol. 83, no. 6, pp. 1176–1183, 2016. View at Publisher · View at Google Scholar
  19. H.-L. Kim, G. E. Chung, I. Y. Park et al., “Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease,” Tohoku Journal of Experimental Medicine, vol. 223, no. 3, pp. 227–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Tilg and A. R. Moschen, “Insulin resistance, inflammation, and non-alcoholic fatty liver disease,” Trends in Endocrinology and Metabolism, vol. 19, no. 10, pp. 371–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Alam, G. Mustafa, M. Alam, and N. Ahmad, “Insulin resistance in development and progression of nonalcoholic fatty liver disease,” World Journal of Gastrointestinal Pathophysiology, vol. 7, no. 2, pp. 211–217, 2016. View at Publisher · View at Google Scholar
  22. S. Stojsavljević, M. G. Palčić, L. V. Jukić, L. S. Duvnjak, and M. Duvnjak, “Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 48, pp. 18070–18091, 2014. View at Publisher · View at Google Scholar
  23. S. H. Park, B. I. Kim, J. W. Yun et al., “Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men,” Journal of Gastroenterology and Hepatology, vol. 19, no. 6, pp. 694–698, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Tasci, T. Dogru, C. N. Ercin, G. Erdem, and A. Sonmez, “Adipokines and cytokines in non-alcoholic fatty liver disease,” Alimentary Pharmacology and Therapeutics, vol. 28, no. 2, pp. 266–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. S. Lieber, “Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis,” Alcohol, vol. 34, no. 1, pp. 9–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Volynets, M. A. Küper, S. Strahl et al., “Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD),” Digestive Diseases and Sciences, vol. 57, no. 7, pp. 1932–1941, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. A. Dawes and S. M. Foster, “The formation of ethanol in Escherichia coli,” Biochimica et Biophysica Acta, vol. 22, no. 2, pp. 253–265, 1956. View at Publisher · View at Google Scholar · View at Scopus
  28. M. V. Machado and H. Cortez-Pinto, “Gut microbiota and nonalcoholic fatty liver disease,” Annals of Hepatology, vol. 11, no. 4, pp. 440–449, 2012. View at Google Scholar · View at Scopus
  29. L. Miele, G. Marrone, C. Lauritano et al., “Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target,” Current Pharmaceutical Design, vol. 19, no. 29, pp. 5314–5324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Ilan, “Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis,” World Journal of Gastroenterology, vol. 18, no. 21, pp. 2609–2618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. L. Harte, N. F. Da Silva, S. J. Creely et al., “Elevated endotoxin levels in non-alcoholic fatty liver disease,” Journal of Inflammation, vol. 7, article 15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. F. J. Verdam, S. S. Rensen, A. Driessen, J. W. Greve, and W. A. Buurman, “Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis,” Journal of Clinical Gastroenterology, vol. 45, no. 2, pp. 149–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Li, S. Yang, H. Lin et al., “Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease,” Hepatology, vol. 37, no. 2, pp. 343–350, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Tilg, R. Jalan, A. Kaser et al., “Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis,” Journal of Hepatology, vol. 38, no. 4, pp. 419–425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Z. Lin, S. Q. Yang, C. Chuckaree, F. Kuhajda, G. Ronnet, and A. M. Diehl, “Metformin reverses fatty liver disease in obese, leptin-deficient mice,” Nature Medicine, vol. 6, no. 9, pp. 998–1003, 2000. View at Publisher · View at Google Scholar · View at Scopus